Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.61
-0.14 (-1.44%)
Jun 2, 2026, 2:50 PM EDT - Market open
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $254.91 million as of June 2, 2026. Its market cap has decreased by -8.04% in one year.
Market Cap
254.91M
Enterprise Value
230.55M
1-Year Change
-8.04%
Ranking
Category
Stock Price
$9.61
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $254.91M, an increase of 339.46%. That is a compound annual growth rate of 40.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 258.62M | 33.73% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 276.16M |
| MacroGenics | 263.14M |
| Context Therapeutics | 256.34M |
| Cellectis | 255.25M |
| Protara Therapeutics | 254.04M |
| Adagene | 249.75M |
| Entrada Therapeutics | 248.99M |
| AC Immune | 244.03M |